Cargando…

The impact of urine microbiota in patients with lower urinary tract symptoms

INTRODUCTION: Inflammation and infection are causative factors of benign prostatic hyperplasia (BPH). Urine is not sterile, and urine microbiota identified by DNA sequencing can play an important role in the development of BPH and can influence the severity of lower urinary tract symptoms (LUTS). MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hsiang-Ying, Wang, Jiunn‐Wei, Juan, Yung-Shun, Li, Ching-Chia, Liu, Chung-Jung, Cho, Sung Yong, Yeh, Hsin-Chih, Chueh, Kuang-Shun, Wu, Wen-Jeng, Wu, Deng‐Chyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051042/
https://www.ncbi.nlm.nih.gov/pubmed/33858430
http://dx.doi.org/10.1186/s12941-021-00428-9
_version_ 1783679686176407552
author Lee, Hsiang-Ying
Wang, Jiunn‐Wei
Juan, Yung-Shun
Li, Ching-Chia
Liu, Chung-Jung
Cho, Sung Yong
Yeh, Hsin-Chih
Chueh, Kuang-Shun
Wu, Wen-Jeng
Wu, Deng‐Chyang
author_facet Lee, Hsiang-Ying
Wang, Jiunn‐Wei
Juan, Yung-Shun
Li, Ching-Chia
Liu, Chung-Jung
Cho, Sung Yong
Yeh, Hsin-Chih
Chueh, Kuang-Shun
Wu, Wen-Jeng
Wu, Deng‐Chyang
author_sort Lee, Hsiang-Ying
collection PubMed
description INTRODUCTION: Inflammation and infection are causative factors of benign prostatic hyperplasia (BPH). Urine is not sterile, and urine microbiota identified by DNA sequencing can play an important role in the development of BPH and can influence the severity of lower urinary tract symptoms (LUTS). MATERIALS AND METHODS: We collected mid-stream voided urine samples from BPH patients and control participants and stored them in a freezer at − 80 °C. All enrolled participants were requested to provide information about their clinical characteristics and complete the International Prostate Symptom Score (IPSS) questionnaire. Each step of the procedure, including the extraction of the genomic DNA from the urine samples; the amplification by polymerase chain reaction (PCR); PCR product quantification, mixing, and purification; DNA library preparation; and sequencing was performed with quality control (QC) measures. Alpha diversity was indicative of the species complexity within individual urine samples, and beta diversity analysis was used to evaluate the differences among the samples in terms of species complexity. Pearson’s correlation analysis was performed to calculate the relationship between the clinical characteristics of the participants and the microbiota species in the urine samples. RESULTS: We enrolled 77 BPH patients and 30 control participants who reported no recent antibiotic usage. Old age, high IPSS and poor quality of life were observed in the participants of the BPH group. No significant differences were observed in the alpha diversity of the samples. In the beta diversity analysis, there was a significant difference between the microbiota in the samples of the BPH and control groups according to ANOSIM statistical analysis. On comparing the groups, the ten bacterial genera present in the samples of the BPH group in descending order of abundance were: Sphingomonas, Bacteroides, Lactobacillus, Streptococcus, Alcaligenes, Prevotella, Ruminococcaceae UCG-014, Escherichia_Shigella, Akkermansia, and Parabacteroides. Spearman’s correlation analysis revealed that urine samples showing the presence of the bacterial genera Haemophilus, Staphylococcus, Dolosigranulum, Listeria, Phascolarctobacterium, Enhydrobacter, Bacillus, [Ruminococcus]torques, Faecalibacterium, and Finegoldia correlated with a high IPSS, and severe storage and voiding symptoms (P < 0.05). CONCLUSION: Our current study shows that dysbiosis of urine microbiota may be related to the development of BPH and the severity of LUTS. Further research targeting specific microbes to identify their role in the development of diseases is necessary and might provide novel diagnostic biomarkers and therapeutic options.
format Online
Article
Text
id pubmed-8051042
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80510422021-04-19 The impact of urine microbiota in patients with lower urinary tract symptoms Lee, Hsiang-Ying Wang, Jiunn‐Wei Juan, Yung-Shun Li, Ching-Chia Liu, Chung-Jung Cho, Sung Yong Yeh, Hsin-Chih Chueh, Kuang-Shun Wu, Wen-Jeng Wu, Deng‐Chyang Ann Clin Microbiol Antimicrob Research INTRODUCTION: Inflammation and infection are causative factors of benign prostatic hyperplasia (BPH). Urine is not sterile, and urine microbiota identified by DNA sequencing can play an important role in the development of BPH and can influence the severity of lower urinary tract symptoms (LUTS). MATERIALS AND METHODS: We collected mid-stream voided urine samples from BPH patients and control participants and stored them in a freezer at − 80 °C. All enrolled participants were requested to provide information about their clinical characteristics and complete the International Prostate Symptom Score (IPSS) questionnaire. Each step of the procedure, including the extraction of the genomic DNA from the urine samples; the amplification by polymerase chain reaction (PCR); PCR product quantification, mixing, and purification; DNA library preparation; and sequencing was performed with quality control (QC) measures. Alpha diversity was indicative of the species complexity within individual urine samples, and beta diversity analysis was used to evaluate the differences among the samples in terms of species complexity. Pearson’s correlation analysis was performed to calculate the relationship between the clinical characteristics of the participants and the microbiota species in the urine samples. RESULTS: We enrolled 77 BPH patients and 30 control participants who reported no recent antibiotic usage. Old age, high IPSS and poor quality of life were observed in the participants of the BPH group. No significant differences were observed in the alpha diversity of the samples. In the beta diversity analysis, there was a significant difference between the microbiota in the samples of the BPH and control groups according to ANOSIM statistical analysis. On comparing the groups, the ten bacterial genera present in the samples of the BPH group in descending order of abundance were: Sphingomonas, Bacteroides, Lactobacillus, Streptococcus, Alcaligenes, Prevotella, Ruminococcaceae UCG-014, Escherichia_Shigella, Akkermansia, and Parabacteroides. Spearman’s correlation analysis revealed that urine samples showing the presence of the bacterial genera Haemophilus, Staphylococcus, Dolosigranulum, Listeria, Phascolarctobacterium, Enhydrobacter, Bacillus, [Ruminococcus]torques, Faecalibacterium, and Finegoldia correlated with a high IPSS, and severe storage and voiding symptoms (P < 0.05). CONCLUSION: Our current study shows that dysbiosis of urine microbiota may be related to the development of BPH and the severity of LUTS. Further research targeting specific microbes to identify their role in the development of diseases is necessary and might provide novel diagnostic biomarkers and therapeutic options. BioMed Central 2021-04-15 /pmc/articles/PMC8051042/ /pubmed/33858430 http://dx.doi.org/10.1186/s12941-021-00428-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lee, Hsiang-Ying
Wang, Jiunn‐Wei
Juan, Yung-Shun
Li, Ching-Chia
Liu, Chung-Jung
Cho, Sung Yong
Yeh, Hsin-Chih
Chueh, Kuang-Shun
Wu, Wen-Jeng
Wu, Deng‐Chyang
The impact of urine microbiota in patients with lower urinary tract symptoms
title The impact of urine microbiota in patients with lower urinary tract symptoms
title_full The impact of urine microbiota in patients with lower urinary tract symptoms
title_fullStr The impact of urine microbiota in patients with lower urinary tract symptoms
title_full_unstemmed The impact of urine microbiota in patients with lower urinary tract symptoms
title_short The impact of urine microbiota in patients with lower urinary tract symptoms
title_sort impact of urine microbiota in patients with lower urinary tract symptoms
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051042/
https://www.ncbi.nlm.nih.gov/pubmed/33858430
http://dx.doi.org/10.1186/s12941-021-00428-9
work_keys_str_mv AT leehsiangying theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT wangjiunnwei theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT juanyungshun theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT lichingchia theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT liuchungjung theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT chosungyong theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT yehhsinchih theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT chuehkuangshun theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT wuwenjeng theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT wudengchyang theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT leehsiangying impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT wangjiunnwei impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT juanyungshun impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT lichingchia impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT liuchungjung impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT chosungyong impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT yehhsinchih impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT chuehkuangshun impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT wuwenjeng impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms
AT wudengchyang impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms